Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Cantor Fitzgerald
Citi
Deloitte
Fuji
Healthtrust
Teva
Mallinckrodt
Argus Health

Generated: April 22, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,066,975

« Back to Dashboard

Which drugs does patent 8,066,975 protect, and when does it expire?

Patent 8,066,975 protects CLOBEX and is included in one NDA.

This patent has thirty-one patent family members in twenty-one countries.
Summary for Patent: 8,066,975
Title:Foaming composition for washing and treating hair and/or scalp based on an active principle
Abstract: The invention concerns a foaming composition for washing and treating hair and/or scalp essentially characterized in that it contains in an aqueous medium: at least an active principle selected among corticoids and retinoids; at least an anionic surfactant; at least an amphoteric surfactant; and a pro-penetrating agent.
Inventor(s): Preuilh; Isabelle (Le Cannet, FR), Guise; Anne-Emmanuelle (Rouen, FR), Willcox; Nathalie (Le Rouret, FR)
Assignee: Galderma S.A. (Cham, CH)
Application Number:11/984,018
Patent Claim Types:
see list of patent claims
Use; Composition;

Drugs Protected by US Patent 8,066,975

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Galderma Labs CLOBEX clobetasol propionate SHAMPOO;TOPICAL 021644-001 Feb 5, 2004 AB RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 8,066,975

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
France98 07802Jun 19, 1998

Non-Orange Book US Patents Family Members for Patent 8,066,975

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,066,976 Foaming compositions for hair care ➤ Sign Up
7,316,810 Foaming composition for washing and treating hair and/or scalp based on an active principle ➤ Sign Up
7,700,081 Foaming compositions for hair care ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Moodys
Citi
Cipla
US Army
McKesson
Healthtrust
Mallinckrodt
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.